Two Sigma Advisers’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $719K | Buy |
|
|||||
|
2025
Q1 | $515K | Sell |
|
|||||
|
2024
Q4 | $433K | Sell |
|
|||||
|
2024
Q3 | $600K | Buy |
|
|||||
|
2024
Q2 | $207K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.52M | Buy |
|
|||||
|
2023
Q1 | $1.44M | Sell |
|
|||||
|
2022
Q4 | $2.08M | Sell |
|
|||||
|
2022
Q3 | $1.43M | Sell |
|
|||||
|
2022
Q2 | $1.81M | Buy |
|
|||||
|
2022
Q1 | $1.3M | Buy |
|
|||||
|
2021
Q4 | $1.51M | Buy |
|
|||||
|
2021
Q3 | $375K | Buy |
|